Delivery Order SPE2DB20D3101-SPE2DB23FREV4
Award Date 3/10/23
Potential Completion Date 3/13/23
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $4,829.60 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024, with a completion date of November 4, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $3,470.13 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a completion date of October 29, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $2,651.84 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2023, with a performance completion date of August 11, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $11,555.07 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 21, 2023, with a completion date of April 24, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,126.01 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024. The contract is a Delivery Order off of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
- The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,923.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. This award is associated with Amerisourcebergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,348.38, was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on October 11, 2023. The contract has an ultimate completion date of October 12, 2023 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a defense agency. The $10,328.41 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 17, 2025 with a completion date of July 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver Xeljanz XR 11 mg tablets. The contract has a ceiling value of $6,252.69 and runs through August 29, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999. The IDC enables the DLA to...
- This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $43,829.52, is a firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of January 6, 2025 and was awarded on January 3, 2025. The award is not associated with a set-aside designation, indicating open...